Detalhe da pesquisa
1.
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
Ann Oncol
; 27(12): 2224-2229, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789469
2.
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).
Ann Oncol
; 26(8): 1734-40, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939894
3.
Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.
Ann Oncol
; 25(7): 1270-1283, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24638905
4.
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.
ESMO Open
; 9(3): 102941, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452437
5.
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).
Ann Oncol
; 24(9): 2382-9, 2013 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788751
6.
Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).
ESMO Open
; 8(2): 101192, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965261
7.
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Ann Oncol
; 23(5): 1223-1229, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21940784
8.
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.
ESMO Open
; 7(1): 100355, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922299
9.
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
Ann Oncol
; 22(7): 1507-1519, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21536661
10.
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.
Ann Oncol
; 22(7): 1528-1534, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21212155
11.
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.
Ann Oncol
; 21(4): 692-706, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717538
12.
Vascular endothelial growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small cell lung cancer.
Expert Opin Pharmacother
; 21(4): 491-506, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957503
13.
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.
Crit Rev Oncol Hematol
; 66(2): 155-62, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18083041
14.
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 23 Suppl 7: vii56-64, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22997455
15.
New antiangiogenetic agents and non-small cell lung cancer.
Crit Rev Oncol Hematol
; 60(1): 76-86, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16843002
16.
First line chemotherapy in advanced or metastatic NSCLC.
Ann Oncol
; 17 Suppl 5: v64-7, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16807466
17.
Chemotherapy of advanced NSCLC in special patient population.
Ann Oncol
; 17 Suppl 5: v72-8, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16807469
18.
Novel immunotherapy in the treatment of advanced non-small cell lung cancer.
Expert Rev Clin Pharmacol
; 9(12): 1571-1581, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623999
19.
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial.
J Clin Oncol
; 17(7): 2081-5, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10561261
20.
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.
J Clin Oncol
; 16(4): 1414-9, 1998 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9552045